WORXD 8-K
SCWorx Corp. (WORX)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported):
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None. |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
As previously reported, on April 10, 2025, Nasdaq notified the Company that based upon the Company’s closing bid price for the previous 30 consecutive business days (February 26, 2025 through April 9, 2025), the Company no longer met the listed securities requirement to maintain a minimum bid price of $1 per share pursuant to Nasdaq Rules 5550(a)(2). On April 14, 2026, the Company was removed from the Nasdaq Stock Market for failing to regain compliance with the Minimum Bid Price Rule.
On April 9, 2026, the Company appealed the Nasdaq Staff’s delisting determination. The Company was granted an appeal of the Nasdaq Staff’s delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. The Company attended its initial appeal meeting on May 12, 2026 and is currently working with the Nasdaq Hearings Panel to demonstrate that the Company has a plan that will enable the Company to satisfy the requirements for re-listing on The Nasdaq Capital Market.
On June 17, 2026, the Hearings Panel notified the company that it would grant the Company continued listing on the Nasdaq Capital Market subject to the completion of certain compliance conditions. Under the terms of the Panel’s decision, SCWorx must demonstrate compliance with Nasdaq’s minimum bid price requirement by achieving a closing bid price of at least $1.00 per share for a minimum of twenty (20) consecutive trading days, as required under Nasdaq Listing Rule 5815(c)(4) subject to the following:
| ● | On or before July 22, 2026, the Company shall obtain shareholder approval for a RSS at a ratio sufficient to achieve a post-split price reasonably expected to sustain compliance with the Bid Price Rule. |
| ● | On or before August 3, 2026, the Company shall have effected a reverse stock split. |
| ● | On or before August 28, 2026, the Company shall demonstrate compliance with the Bid Price Rule by evidencing a closing bid price at or above $1.00 per share for a minimum of 20 consecutive trading days. |
On July 24, 2026, the Company received a partial compliance letter from Nasdaq confirming the Company’s compliance with the first provision of its compliance plan to regain Nasdaq Eligibility.
The Company is currently working to regain compliance with all applicable Nasdaq Listing Rules. However, there can be no assurance that if the Company will be successful.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit | Description | |
| 99.1 | Press release dated July 29, 2026* | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| * | Filed herwith |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 29, 2026
| SCWorx Corp. | ||
| By: | /s/Timothy A. Hannibal | |
| Name: | Timothy A. Hannibal | |
| Title: | Chief Executive Officer | |
2
Exhibit 99.1
SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market
MIDDLETON, MA – July 29, 2026 – SCWorx Corp. (“SCWorx” or the “Company”), a provider of data normalization and supply chain solutions for the healthcare industry, today announced that it has received a partial compliance letter from the Nasdaq Hearings Panel (the “Panel”) confirming completion of the first benchmark for the Company’s approved plan to regain compliance for continued listing on The Nasdaq Capital Market.
Under the terms of the Panel’s previous decision, SCWorx must demonstrate compliance with Nasdaq’s minimum bid price requirement by achieving a closing bid price of at least $1.00 per share for a minimum of twenty (20) consecutive trading days, as required under Nasdaq Listing Rule 5815(c)(4).
The company must still immediately notify Nasdaq of any material changes to its compliance plan or any event, condition, or circumstance that could affect the Company’s ability to satisfy the requirements of the exception granted previously. The Panel also reserved the right to reconsider the terms of the exception should any developments arise that, in the Panel’s judgment, make continued listing of the Company’s securities inadvisable or unwarranted.
“We appreciate the Panel’s continued consideration and for the opportunity to continue our Nasdaq listing while we execute the next phases of our compliance plan,” said Tim Hannibal, President and Chief Executive Officer of SCWorx. “Maintaining our Nasdaq listing remains a strategic priority as we continue to focus on expanding customer relationships, advancing our healthcare supply chain data management platform, and creating long-term value for shareholders.”
The Company intends to take all actions necessary to satisfy the conditions established by the Panel and will continue to keep investors informed regarding its progress.
About SCWorx Corp.
SCWorx is a provider of data management and analytics solutions focused on improving operational efficiency, data accuracy, and cost savings for healthcare organizations. The Company’s platform enables the normalization, aggregation, and analysis of complex data sets to support supply chain optimization, financial performance, and regulatory compliance.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. SCWorx undertakes no obligation to update any forward-looking statements except as required by law.
Investor Relations Contact:
SCWorx Investor Relations